Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2020.02.04.934885

Bacterial Growth Stimulation and Antifungal Effects Of The Essential-oil-less-extracts Of The Food Spice Dysphania ambrosioides

Nitsch-Velasquez, L.
View original source ↗Export metadata ↓

Abstract

1D. ambrosioides leaves (DaL) are utilized as food spice. DaL infusion is utilized as antihelminthic in traditional medicine, the extracted essential oil (EO) has been repurposed as biopesticide, in vitro activities include nematocidal and phytotoxic activities by hydrophillic compounds from leaves and the roots. As Da might be a good candidate for circular economy, more potential applications of the essential-oil-less-Da extracts were pursued by applying green chemistry based extraction methods. DaL extracts were prepared by the autoclave method for the sterile-essential-oil-less aqueous extract (SALAEL-Da), butanol fractionating for saponins extraction (SAP) and ethanol boiling method for the saponin-free extract (EtOH-Da). Their effects over clinical isolates of fungi (Candida albicans / CA), gram-negative bacteria (Erwinia carotovora / ErC) and -positive (Methicillin resistant Staphylococcus aureus USA 300 / MRSA-USA-300). were explored. The raw extracts stimulated the bacterial growth of all strains in the pre-screening phase. SALAEL-DaL (at 25 mg/mL) estimulated ErC growth, reducint its doubling time by 35%, microdilutions of EtOH-DaL (at 180 mg/mL) stimulated the growth of MRSA-USA-300 even in the GEN presence at sub-lethal concentrations (MICGEN=1.75{micro}g/mL). SALAEL-Da (at 137 mg/mL) inhibited the growth of CA in agar dilutions, and its fraction SAP showed a moderated fungistatic effect at 100 mg/mL in disk diffusion pre-screening tests. SAP fraction may partially account for the observed antifungal activity. The essential-oil-less-Da aqueous extracts analyzed contained bacterial growth stimulating and antifungal components. Further investigation may lead to commercial opportunities for probiotics and antifungals. 2 ImportanceThe leaves of D. ambrosioides (Da) are utilized as food spice and its infusion as antihelminthic in Latin American folk medicine, with a wide variety of in vitro bioactivities reported. The most studied is Da essential oil (Da-EO) and has been repurposed as insect repellent and pesticide. Which would leave the extracted plant material as a potential raw material for other products. Additionally, Da could be an interesting candidate tobe produced at high-scale in rural communities. The ecofriendly extraction processes yielded an aqueous extract (free of the EO) that enhances the bacterial growth rate of two bacterial strains, which can eventually be useful in the probiotics industry. This extract also inhibited the growth of the opportunistic fungi Candida albicans, becoming a potential source of new antifungals. Further investigation may lead to a circular economy of the agroindustry around D. ambrosioides, probiotics and antifungals, among others.

Explore related subjects

microbiologyPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Nitsch-Velasquez, L.. 2020-02-05. Bacterial Growth Stimulation and Antifungal Effects Of The Essential-oil-less-extracts Of The Food Spice Dysphania ambrosioides. https://doi.org/10.1101/2020.02.04.934885

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗
bioRxiv2026

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗
bioRxiv2026

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗